MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/jac/dkag267

Медицинская библиотека · The Journal of antimicrobial chemotherapy · 2026

Clinical characteristics and outcomes of patients with bacteraemia caused by non-carbapenemase-producing, carbapenem-resistant Enterobacterales.

Shah Sunish, Clarke Lloyd G, Kline Ellen G, Marini Rachel V, Squires Kevin M, Shields Ryan K

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

Carbapenem-resistant Enterobacterales (CRE) are classified as carbapenemase- and non-carbapenemase-producing (non-CP) CRE. The purpose of this study was to identify factors associated with meropenem non-susceptible non-CP CRE to help stratify treatment approaches and to report rates of treatment-emergent resistance among patients with non-CP CRE bacteraemia.

METHODS

This was a retrospective, single-centre study of patients hospitalized between January 2015 and September 2025 with bacteraemia due to Enterobacterales resistant to ertapenem and confirmed to be non-CP. Ertapenem resistance was determined by broth microdilution susceptibility testing. Carbapenemase testing was performed by modified carbapenem-inactivation method, polymerase chain reaction or whole-genome sequencing.

RESULTS

Among 60 patients who met the inclusion criteria, the median (IQR) age was 63 years (57-73), 33% (20/60) were female and 18% (11/60) were organ transplant recipients. Patients infected with meropenem non-susceptible non-CP CRE were more likely to have prior meropenem exposure [60% (10/15) versus 13% (8/45), P < 0.001] and have breakthrough bacteraemia [60% (9/15) versus 29% (13/45), P = 0.031]. Treatment-emergent resistance developed in 16% (4/24) and 0% (0/15) of patients treated with meropenem and ceftazidime-avibactam, respectively.

CONCLUSIONS

These exploratory data provide new insights into clinical factors associated with meropenem non-susceptible non-CP CRE and support future investigations into the comparative-effectiveness of meropenem versus beta-lactam/beta-lactamase inhibitors for the treatment of meropenem-susceptible non-CP CRE.

Для цитирования: Shah Sunish, Clarke Lloyd G, Kline Ellen G, Marini Rachel V, Squires Kevin M, Shields Ryan K. Clinical characteristics and outcomes of patients with bacteraemia caused by non-carbapenemase-producing, carbapenem-resistant Enterobacterales.. The Journal of antimicrobial chemotherapy. 2026. DOI: 10.1093/jac/dkag267.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.